GeneTrait Pain Management Panel
GeneTrait’s Pain Management panel evaluates genetic markers responsible for metabolism of many common pain management medications including opiates, NSAIDs, methotrexate, and tricyclic antidepressants, plus elevated risk of hyperhomocysteinemia.
NUMBER OF INDIVIDUAL GENES TESTED:
- Tricyclic Antidepressants
RISK FACTORS EVALUATED: